DK1380302T3 - Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel - Google Patents
Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddelInfo
- Publication number
- DK1380302T3 DK1380302T3 DK02708676T DK02708676T DK1380302T3 DK 1380302 T3 DK1380302 T3 DK 1380302T3 DK 02708676 T DK02708676 T DK 02708676T DK 02708676 T DK02708676 T DK 02708676T DK 1380302 T3 DK1380302 T3 DK 1380302T3
- Authority
- DK
- Denmark
- Prior art keywords
- active ingredient
- retinal
- medicines
- diseases containing
- containing steroids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001092329 | 2001-03-28 | ||
PCT/JP2002/002950 WO2002078713A1 (fr) | 2001-03-28 | 2002-03-27 | Medicaments contre les affections retiniennes et choroidiennes contenant des steroides comme principe actif |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1380302T3 true DK1380302T3 (da) | 2008-12-08 |
Family
ID=18946808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02708676T DK1380302T3 (da) | 2001-03-28 | 2002-03-27 | Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040097478A1 (el) |
EP (1) | EP1380302B1 (el) |
KR (1) | KR100854058B1 (el) |
CN (1) | CN100353947C (el) |
AT (1) | ATE405274T1 (el) |
CA (1) | CA2442296C (el) |
CY (1) | CY1108572T1 (el) |
DE (1) | DE60228431D1 (el) |
DK (1) | DK1380302T3 (el) |
ES (1) | ES2311592T3 (el) |
PT (1) | PT1380302E (el) |
WO (1) | WO2002078713A1 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1835735B (zh) * | 2003-08-20 | 2010-05-12 | 参天制药株式会社 | 微粒眼球筋膜下给药的药物释放*** |
US7374219B2 (en) * | 2004-09-22 | 2008-05-20 | Zephyros, Inc. | Structural reinforcement member and method of use therefor |
RU2696045C1 (ru) * | 2018-10-15 | 2019-07-30 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ лечения болезни Илза |
IT201900014052A1 (it) * | 2019-08-05 | 2021-02-05 | Lucia Scorolli | Preparazione para-bulbare con effetto citotrofico-retinico |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454151A (en) * | 1982-03-22 | 1984-06-12 | Syntex (U.S.A.) Inc. | Use of pyrrolo pyrroles in treatment of ophthalmic diseases |
JPS61106521A (ja) * | 1984-10-31 | 1986-05-24 | Kureha Chem Ind Co Ltd | 血管増殖抑制剤 |
JPH05500054A (ja) * | 1989-08-28 | 1993-01-14 | アルコン ラボラトリーズ インコーポレイテッド | 眼科組成物 |
US5104787A (en) * | 1990-03-05 | 1992-04-14 | Lindstrom Richard L | Method for apparatus for a defined serumfree medical solution useful for corneal preservation |
KR0185215B1 (ko) * | 1990-11-30 | 1999-05-01 | 요시다 쇼오지 | 서방성 안구삽입용 약제 |
EP0614463B1 (en) * | 1991-11-22 | 2003-02-12 | Alcon Laboratories, Inc. | Angiostatic steroids |
EP0632726A4 (en) * | 1991-12-20 | 1995-11-29 | Us Army | METHOD FOR TREATING KAPOSI'S DISEASE AND BLOCKING OR INHIBITING VASCULAR PERMEABILITY. |
WO1995003807A1 (en) * | 1993-07-27 | 1995-02-09 | The University Of Sydney | Treatment of age-related macular degeneration |
TW420611B (en) * | 1995-03-10 | 2001-02-01 | R Tech Ueno Ltd | Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder |
AU6763496A (en) * | 1995-08-07 | 1997-03-05 | Schering Corporation | Treatment of ocular inflammatory conditions with interleukin-10 |
DK1920773T3 (da) * | 1996-11-05 | 2011-03-28 | Childrens Medical Center | Thalidomid og dexamethason til behandling af tumorer |
US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6395294B1 (en) * | 2000-01-13 | 2002-05-28 | Gholam A. Peyman | Method of visualization of the vitreous during vitrectomy |
US6726918B1 (en) * | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
-
2002
- 2002-03-27 US US10/473,512 patent/US20040097478A1/en not_active Abandoned
- 2002-03-27 DE DE60228431T patent/DE60228431D1/de not_active Expired - Lifetime
- 2002-03-27 CA CA2442296A patent/CA2442296C/en not_active Expired - Fee Related
- 2002-03-27 EP EP02708676A patent/EP1380302B1/en not_active Expired - Lifetime
- 2002-03-27 WO PCT/JP2002/002950 patent/WO2002078713A1/ja active IP Right Grant
- 2002-03-27 PT PT02708676T patent/PT1380302E/pt unknown
- 2002-03-27 KR KR1020037012670A patent/KR100854058B1/ko not_active IP Right Cessation
- 2002-03-27 CN CNB028074858A patent/CN100353947C/zh not_active Expired - Fee Related
- 2002-03-27 AT AT02708676T patent/ATE405274T1/de active
- 2002-03-27 ES ES02708676T patent/ES2311592T3/es not_active Expired - Lifetime
- 2002-03-27 DK DK02708676T patent/DK1380302T3/da active
-
2008
- 2008-11-17 CY CY20081101320T patent/CY1108572T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2442296A1 (en) | 2002-10-10 |
EP1380302A4 (en) | 2006-04-12 |
CY1108572T1 (el) | 2014-04-09 |
CA2442296C (en) | 2010-06-22 |
CN100353947C (zh) | 2007-12-12 |
ES2311592T3 (es) | 2009-02-16 |
KR20030087029A (ko) | 2003-11-12 |
EP1380302B1 (en) | 2008-08-20 |
DE60228431D1 (de) | 2008-10-02 |
EP1380302A1 (en) | 2004-01-14 |
US20040097478A1 (en) | 2004-05-20 |
PT1380302E (pt) | 2008-11-25 |
KR100854058B1 (ko) | 2008-08-26 |
CN1551775A (zh) | 2004-12-01 |
ATE405274T1 (de) | 2008-09-15 |
WO2002078713A1 (fr) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4466973A (en) | Method of treating nasal and sinus congestion | |
HRP20050781B1 (hr) | Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu | |
US20060228306A1 (en) | Combination antihistamine and steroid medication | |
NO20060200L (no) | Farmasoytisk formulering for prevensjons- og hormonerstatningsterapier | |
DE69930252D1 (de) | Verwendung von tetracyclinen zur behandlung von störungen der meibomschen drüsen | |
CA2502437A1 (en) | Method and composition containing latanoprost for treating ocular hypertension and glaucoma | |
NO954925L (no) | Metode for behandling av smerte ved administrering av 24 timers orale opioidformuleringer som utviser hurtig stigningsgrad av plasmalegemiddelnivå | |
BRPI0409381A (pt) | formulações farmacêuticas nasais e métodos de utilizar as mesmas | |
NO925038L (no) | Anordning for nedsettelse av medikamentets hudirriterendevirkninger | |
JPH0269413A (ja) | アレルギー性鼻炎の治療方法 | |
BRPI0409434A (pt) | formulações farmacêuticas nasais e métodos para usar as mesmas | |
DE60214527D1 (de) | Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit | |
DK1380302T3 (da) | Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel | |
SE9803761D0 (sv) | Method to avoid increased iridial pigmentation during prostaglandin treatment | |
YU6196A (sh) | Transdermalna flasterska formulacija | |
HUP0302036A2 (hu) | Glükokortikoidot tartalmazó készítmény bronchopulmonális betegségek kezelésére | |
DK1343472T3 (da) | Thixotropisk næsespray | |
ATE280578T1 (de) | Kombination von einem den retinoinsäure metabolismus blockierenden arzneimittel und einem tocopherol | |
TWI713618B (zh) | 外用劑 | |
DK1492539T3 (da) | Statin-terapi til forögelse af kognitiv funktion | |
EP4151210A3 (en) | Pyridine-carboline derivatives as mchr1 antagonists for use in therapy | |
DK0654267T3 (da) | Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent | |
ES2779525T3 (es) | Composición que comprende un éster de alfa-tocoferol para prevención y tratamiento de rinitis alérgica | |
JP3512277B2 (ja) | 鼻茸治療・予防剤 | |
Werner | New drugs for improving injury outcome in spinal cord injuries. |